Mick Mulvaney Archives - CDR – Chain Drug Review

Trump budget would cut health care funds

June 5, 2017 by Greg Jacobson and Chain Drug Review Centers for Disease Control and Prevention, cuts in health care, Department of Health and Human Services, fiscal 2018 U.S. budget, Food and Drug Administration, Mick Mulvaney, National Institutes of Health 2017, Issue 06-05-2017, Issues, News

WASHINGTON — The fiscal 2018 U.S. budget issued by the Trump administration calls for steep cuts in health care and scientific research while heavily boosting defense spending and offering substantial tax cuts. Dubbed “A New Foundation for American Greatness,” the spending plan was touted as a “taxpayer first” budget by Mick Mulvaney, director of the

Lawmakers push for action on drug costs

May 18, 2017 by Chain Drug Review Amy Klobuchar, Chuck Grassley, FAIR Drug Pricing Act, Jan Schakowsky, John McCain, Mick Mulvaney, Office of Management and Budget, prescription drug costs, prescription drug importation from Canada, prescription drug market, Safe and Affordable Drugs from Canada Act, Tammy Baldwin, Tom Price Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Sens. John McCain (R., Ariz.) and Tammy Baldwin (D., Wis.) and Rep. Jan Schakowsky (D., Ill.) this week reintroduced the Fair Accountability and Innovative Research (FAIR) Drug Pricing Act, aimed at improving cost transparency for pharmaceutical price hikes. The FAIR Drug Pricing Act would require drug manufacturers to notify the Department of Health